Concepedia

Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension

Jérôme Avouac, Irena Konstantinova, Christophe Guignabert, Sonia Pezet, Jérémy Sadoine, Thomas Guilbert, Anne Cauvet, Ly Tu, Jean‐Michel Luccarini, Jean‐Louis Junien,

Annals of the Rheumatic Diseases · 2017 · 81 citations · 30 references

DOI

Concepts

References

30

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiéry et al. · European Respiratory Journal · 2015 · 3.2K citations · Full text

, , +15

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

Marc Humbert, Olivier Sitbon, A. Yaïci et al. · European Respiratory Journal · 2010 · 670 citations · Full text

, , +8

Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis

Katrin Palumbo‐Zerr, Pawel Zerr, Alfiya Distler et al. · Nature Medicine · 2015 · 341 citations

, , +13

PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis

Jami E. Milam, Venkateshwar G. Keshamouni, Sem H. Phan et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2007 · 214 citations · Full text

, , +14

Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension

Nicolas Ricard, Ly Tu, Morane Le Hiress et al. · Circulation · 2014 · 203 citations

, , +14